Chlamydia trachomatis infection in women with CIN and invasive uterine cervix cancer. Significance of hormonal status

European Journal of Gynaecological Oncology

Volumn 23, Issue 6, 2002, Pages 511-513

  Markowska, J ^a   Fischer, N ^b   Fischer, Z ^b   Warchol J B ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Medical School ^*

Author keywords

Cervical cancer; Cht infection; CIN; Hormonal status

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE ACTION; HUMAN; HUMAN TISSUE; HYPERTROPHY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

ADULT; AGE FACTORS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DNA PRIMERS; FEMALE; HORMONES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; UTERINE CERVICAL NEOPLASMS;

EID: 0036950564     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Anttila T., Saikku P., Koskela P., et al.: "Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma". J.A.M.A., 2000, 285, 47.
2. Beatty W. L., Morrison R. P., Byrne G. L.: "Persistent Chlamydiae". Microbial. Rev., 1994, 58, 686.
3. Blum H., Benaim J.: "Activities of a family planning clinic incorporated to a public medical service over a 4-year period". Rev. Fr. Gynecol. Obstet., 1991, 86 (5), 381.
4. Bose S. K., Goswami P. C.: "Enhancement of adherence and growth of Chlamydia trachomatis by estrogen treatment of HeLa cells". Infect. Immun., 1986, 53 (3), 646.
5. Koivisto A. L., Isoacho R., von Hertzen L., et al.: "Chlamydial antibodies in an elderly Finnish population". Scand. J. Infect. Dis., 1999, 31 (2), 135.
6. Koskela P., Anttila T., Björge T., et al.: "Chlamydia trachomatis infection as a risk for invasive cervical carcinoma". Int. J. Cancer. 2000, 85. 35.
7. Markowska J., Fischer N., Filas V., et al.: "The role of Chlamydia trachomatis infection in cervical cancer development". Eur. J. Gynaecol. Oncol., 1999, 20 (2), 144.
8. Puolakkainen M., Vesterinen E., Purola E., et al.: "Persistence of chlamydial antibodies after pelvic inflammatory disease". J. Clin. Microbiol., 1986, 23, 924.
9. Suchet H.: "Hormonal contraception and pelvic inflammatory disease". Eur. J. Contracept. Reprod. Health Care. 1997, 4, 267.
10. Wallin K. L., Wiklund F., Angström T., et al.: "Type-specific persistence of human papilloma virus DNA before the development of invasive cervical cancer". N. Engl. J. Med., 1999, 341, 1633.
11. Zdrodowska Stefanow B., Ostaszewska J.: "Chlamydia trachomatis - infections in humans (in Polish)", 2000.
12. Zur Hausen H.: "Cervical carcinoma and human papilloma virus: on the road to preventing a major human cancer". J. Natl. Cancer Inst., 2001, 93 (4), 252.